NanoString Technologies (NASDAQ: NSTG)
Some price data may be temporarily unavailable.
NanoString Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NanoString Technologies Company Info
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA.
News & Analysis
Why Shares of NanoString Technologies Are Falling Thursday
The company lost a patent ruling in Germany to life sciences competitor 10x Genomics.
3 Small-Cap Stocks With Large-Cap Potential
These three small companies have the potential to make you a lot of money.
NanoString Technologies Delivers 21% Revenue Growth in Q2
All eyes were on a new instrument launch, which got off to a strong start judging from pre-orders.
What to Watch When NanoString Technologies Reports Q2 Results
Investors will be focused on a potentially trajectory-altering product launch, but it will be several quarters (at least) before we can start drawing conclusions about its impact.
Here's Why NanoString Technologies Stock Soared 104.7% in the First Half of 2019
Investors are excited (perhaps a little too excited) about a new opportunity in immuno-oncology.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.